
PsychRounds: The Psychiatry Podcast
by Dr. Tanner Hewitt, Dr. Larry Wang and Dr. Bradley Miller
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 19 chart positions in 19 markets.
By chart position
- 🇺🇸US · Medicine#5930K to 100K
- 🇦🇺AU · Medicine#7530K to 100K
- 🇨🇦CA · Medicine#1535K to 30K
- 🇮🇳IN · Medicine#10100K to 300K
- 🇯🇵JP · Medicine#5810K to 30K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
139K to 453K🎙 ~2x weekly·109 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
278K to 905K🇮🇳33%🇺🇸11%🇦🇺11%+16 more - Active Followers
Loyal subscribers who consistently listen
83K to 272K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 14 epsHosts
Recent guests
Recent episodes
The Rising Use of Recreational Kratom
Jul 8, 2026
21m 13s
Modafinil (Provigil)
Jun 3, 2026
19m 36s
Naltrexone
May 20, 2026
16m 10s
Placebo Effect and Response in Psychiatry
May 6, 2026
22m 14s
Amantadine (Symmetrel)
Apr 8, 2026
17m 01s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/8/26 | recreational drug useKratom+3 | — | Kratom | — | Kratomrecreational use+3 | — | 21m 13s | ||
| 6/3/26 | Modafinilpsychiatry+4 | — | ModafinilTeva Pharmaceuticals USA, Inc.+5 | — | ModafinilProvigil+5 | — | 19m 36s | ||
| 5/20/26 | medicationpsychiatry+3 | — | NaltrexoneNCBI+2 | — | Naltrexonepsychiatry+3 | — | 16m 10s | ||
| 5/6/26 | placebo effectpsychiatry+3 | — | PubMedNCBI+2 | — | placebo effectpsychiatry+3 | — | 22m 14s | ||
| 4/8/26 | Amantadinepsychiatry+3 | — | AmantadineSymmetrel | — | AmantadineSymmetrel+3 | — | 17m 01s | ||
| 3/21/26 | tardive dyskinesiaVMAT2 inhibitors+3 | — | Valbenazine (Ingrezza)Deutetrabenazine (Austedo)+3 | — | tardive dyskinesiaVMAT2 inhibitors+3 | — | 17m 19s | ||
| 2/25/26 | DSMPsychiatry+3 | Dr. Allen Frances | DSM IIIDSM IV | — | DSMAllen Frances+3 | — | 55m 50s | ||
| 1/28/26 | psychiatrymedication+3 | — | TopiramateTopamax+2 | — | TopiramateTopamax+3 | — | 15m 19s | ||
| 1/14/26 | psychiatric illnesspsychotherapy+3 | Dr. Mark Ruffalo | University of Central Florida College of MedicineTufts University School of Medicine+2 | — | psychiatric illnesspsychotherapy+3 | — | 54m 32s | ||
| 12/31/25 | benzodiazepinepsychiatry+3 | — | LorazepamAtivan+3 | — | LorazepamAtivan+5 | — | 14m 27s | ||
| 12/17/25 | iron deficiencymental health+3 | — | NCBIScienceDirect+3 | — | iron deficiencypsychiatry+4 | — | 25m 24s | ||
| 12/3/25 | Nutritional PsychiatryMental Health+3 | Dr. Laura Lachance | EASe-GAD trialAntidepressant Food Score+1 | — | Nutritional PsychiatryAntidepressant Food Score+4 | — | 49m 18s | ||
| 11/19/25 | stressculture+3 | Dr. Robert Sapolsky | Stanford UniversityInstitute of Primate Research+3 | — | stressculture+5 | — | 1h 03m 08s | ||
| 11/5/25 | SSRIsmental health+3 | — | Selective Serotonin Reuptake Inhibitors | — | SSRIsSelective Serotonin Reuptake Inhibitors+3 | — | 32m 53s |
Showing 14 of 14
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Similar Audience Demographics
Podcasts that attract a similar listener profile
Chart history for PsychRounds: The Psychiatry Podcast
Peaked at #9 in CL, top 10 in 2 of 22 tracked markets, currently #9 in CL.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| CL | — | #9 | #9 | — |
| India | — | #10 | #10 | — |
| South Africa | — | #17 | #17 | — |
| RO | — | #29 | #29 | — |
| PL | — | #31 | #31 | — |
| PT | — | #41 | #41 | — |
| India | — | #50 | #50 | — |
| Japan | — | #58 | #58 | — |
| United States | — | #59 | #59 | — |
| Australia | — | #75 | #75 | — |
| SG | — | #75 | #75 | — |
| CL | — | #75 | #75 | — |
| KE | — | #90 | #90 | — |
| Denmark | — | #96 | #96 | — |
| Finland | — | #108 | #108 | — |
| NG | — | #120 | #120 | — |
| IL | — | #138 | #138 | — |
| Brazil | — | #138 | #138 | — |
| Canada | — | #153 | #153 | — |
| South Africa | — | #153 | #153 | — |
Chart Positions
22 placements across 19 markets.
Chart Positions
22 placements across 19 markets.